NOV Inc. price target raised to $20 from $17 at Barclays

Barclays analyst J. David Anderson raised the firm’s price target on NOV Inc. to $20 from $17 and keeps an Underweight rating on the shares. The company posted a solid Q2 with an EBITDA beat, impressive order inbound, higher margins and strong free cash flow, but these were offset by a softer second half of 2024 guide, the analyst tells investors in a research note.